CLINICAL_TRIALS
trial_result
· 2017-07-31
Clinical Trial Update: Studying the Effects of Sibutramine on Eating Behavior [Phase 4]
Summary
A Phase 4 trial evaluating sibutramine for obesity was terminated, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Obesity | Phase 4 | Status: TERMINATED | Results posted: 2017-07-31